Adial Pharmaceuticals has partnered with Boudicca Dx to develop a companion diagnostic test for AD04, a potential treatment for Alcohol Use Disorder. The test will be validated to FDA guidelines and is expected to help identify and recruit patients for the upcoming Phase 3 study of AD04.